Clinical Trial Update: Tocilizumab REMission in Early RA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on tocilizumab in early rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: University of Leeds | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED